Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Retrovirus-mediated tk gene therapy of implanted human breast cancer in nude mice under the regulation of Tet-On

Abstract

Tight regulation of the therapeutic gene expression is critical in gene therapy. In this report, a doxycycline (Dox)-regulated retrovirus-mediated gene expression system was used to study the effects of suicide gene therapy on human breast cancer cell line MCF-7 and the nude mice model of implanted human breast cancer. To render the expression of suicide gene under control, we used two pseudoviruses simultaneously, RevTRE/HSVtk and RevTet-On, to infect MCF-7 cells or xenografts of nude mice. When infected by the pseudoviruses and followed by Dox and Ganciclovir (GCV) treatment, MCF-7 cells were arrested at S phase and the growth was suppressed. We then evaluated the antitumor efficiency of this system in vivo through studying the mice bearing human breast cancer xenografts. Compared with control groups, the HSVtk mRNA level increased significantly in tumor tissues, mass of the tumors shrank remarkably, and tumor necrosis features occurred after treatment with Dox and GCV. These data suggest that suicide gene therapy using the Dox-induced Tet-On-controlled HSVtk gene expression system is a feasible method to treat human breast cancer.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. Wiewrodt R, Amin K, Kiefer M, Jovanovic VP, Kapoor V, Force S et al. Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing. Cancer Gene Ther 2003; 10 (5): 353–364.

    Article  CAS  PubMed  Google Scholar 

  2. Asklund T, Appelskog IB, Ammerpohl O, Langmoen IA, Dilber MS, Aints A et al. Gap junction-mediated bystander effect in primary cultures of human malignant gliomas with recombinant expression of the HSVtk gene. Exp Cell Res 2003; 284 (2): 185–195.

    Article  CAS  PubMed  Google Scholar 

  3. Zhong Q, Kolls JK, Schwarzenberger P . Retrovirus molecular conjugates. A novel, high transduction efficiency, potentially safety-improved, gene transfer system. J Biol Chem 2001; 276 (27): 24601–24607.

    Article  CAS  PubMed  Google Scholar 

  4. Bai Y, Soda Y, Izawa K, Tanabe T, Kang X, Tojo A et al. Effective transduction and stable transgene expression in human blood cells by a third-generation lentiviral vector. Gene Therapy 2003; 10 (17): 1446–1457.

    Article  CAS  PubMed  Google Scholar 

  5. Hillman GG, Slos P, Wang Y, Wright JL, Layer A, De Meyer M et al. Tumor irradiation followed by intratumoral cytokine gene therapy for murine renal adenocarcinoma. Cancer Gene Ther 2004; 11: 61–72.

    Article  CAS  PubMed  Google Scholar 

  6. Zabala M, Wang L, Hernandez-Alcoceba R, Hillen W, Qian C, Prieto J et al. Optimization of the Tet-On system to regulate interleukin 12 expression in the liver for the treatment of hepatic tumors. Cancer Res 2004; 64 (8): 2799–2804.

    Article  CAS  PubMed  Google Scholar 

  7. Koponen JK, Kankkonen H, Kannasto J, Wirth T, Hillen W, Bujard H et al. Doxycycline-regulated lentiviral vector system with a novel reverse transactivator rtTA2S-M2 shows a tight control of gene expression in vitro and in vivo. Gene Therapy 2003; 10 (6): 459–466.

    Article  CAS  PubMed  Google Scholar 

  8. Tang Y, Jackson M, Qian K, Phillips MI . Hypoxia inducible double plasmid system for myocardial ischemia gene therapy. Hypertension 2002; 39 (2, Part 2): 695–698.

    Article  CAS  PubMed  Google Scholar 

  9. Dalle B, Payen E, Beuzard Y . Modulation of transduced erythropoietin expression by iron. Exp Hematol 2000; 28 (7): 760–764.

    Article  CAS  PubMed  Google Scholar 

  10. Worthington J, McCarthy HO, Barrett E, Adams C, Robson T, Hirst DG . Use of the radiation-inducible WAF1 promoter to drive iNOS gene therapy as a novel anti-cancer treatment. J Gene Med 2004; 6 (6): 673–680.

    Article  CAS  PubMed  Google Scholar 

  11. Schmeisser F, Donohue M, Weir JP . Tetracycline-regulated gene expression in replication-incompetent herpes simplex virus vectors. Hum Gene Ther 2002; 13 (18): 2113–2124.

    Article  CAS  PubMed  Google Scholar 

  12. A-Mohammadi S, Hawkins RE . Efficient transgene regulation from a single tetracycline-controlled positive feedback regulatory system. Gene therapy 1998; 5 (1): 76–84.

    Article  CAS  PubMed  Google Scholar 

  13. Kim HJ, Gatz C, Hillen W, Jones TR . Tetracycline repressor-regulated gene repression in recombinant human cytomegalovirus. J Virol 1995; 69 (4): 2565–2573.

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Chtarto A, Bender HU, Hanemann CO, Kemp T, Lehtonen E, Levivier M et al. Tetracycline-inducible transgene expression mediated by a single AAV vector. Gene Therapy 2003; 10 (1): 84–94.

    Article  CAS  PubMed  Google Scholar 

  15. Ginhoux F, Turbant S, Gross DA, Poupiot J, Marais T, Lone Y et al. HLA-A*0201-restricted cytolytic responses to the rtTA transactivator dominant and cryptic epitopes compromise transgene expression induced by the tetracycline on system. Mol Ther 2004; 10 (2): 279–289.

    Article  CAS  PubMed  Google Scholar 

  16. Gimenez E, Lavado A, Giraldo P, Cozar P, Jeffery G, Montoliu L . A transgenic mouse model with inducible Tyrosinase gene expression using the tetracycline (Tet-On) system allows regulated rescue of abnormal chiasmatic projections found in albinism. Pigment Cell Res 2004; 17 (4): 363–370.

    Article  CAS  PubMed  Google Scholar 

  17. Laposa RR, Henderson JT, Wells PG . Tetracycline-dependent regulation of formamidopyrimidine DNA glycosylase in transgenic mice conditionally reduces oxidative DNA damage in vivo. FASEB J 2003; 17 (10): 1343–1345.

    Article  CAS  PubMed  Google Scholar 

  18. Hu WX, Zeng ZJ, Luo SQ, Chen Q . Suicide gene therapy of human breast cancer in SCID mice model by the regulation of Tet-On. Chin Med J (Engl) 2004; 117 (3): 434–439.

    CAS  Google Scholar 

  19. Sheridan PL, Bodner M, Lynn A, Phuong TK, DePolo NJ, de la Vega Jr DJ et al. Generation of retroviral packaging and producer cell lines for large-scale vector production and clinical application: improved safety and high titer. Mol Ther 2000; 2 (3): 262–275.

    Article  CAS  PubMed  Google Scholar 

  20. Jordan M, Wurm F . Transfection of adherent and suspended cells by calcium phosphate. Methods 2004; 33 (2): 136–143.

    Article  CAS  PubMed  Google Scholar 

  21. Lake DE, Hudis CA . High-dose chemotherapy in breast cancer. Drugs 2004; 64 (17): 1851–1860.

    Article  CAS  PubMed  Google Scholar 

  22. Kim KB, Eton O, East MJ, Hodges C, Papadopoulos NE, Grimm EA et al. Pilot study of high-dose, concurrent biochemotherapy for advanced melanoma. Cancer 2004; 101 (3): 596–603.

    Article  CAS  PubMed  Google Scholar 

  23. Brade AM, Szmitko P, Ngo D, Liu FF, Klamut HJ . Heat-directed suicide gene therapy for breast cancer. Cancer Gene Ther 2003; 10 (4): 294–301.

    Article  CAS  PubMed  Google Scholar 

  24. Kanazawa T, Mizukami H, Okada T, Hanazono Y, Kume A, Nishino H et al. Suicide gene therapy using AAV-HSVtk/ganciclovir in combination with irradiation results in regression of human head and neck cancer xenografts in nude mice. Gene Therapy 2003; 10 (1): 51–58.

    Article  CAS  PubMed  Google Scholar 

  25. Zerrouqi A, Rixe O, Ghoumari AM, Yarovoi SV, Mouawad R, Khayat D et al. Liposomal delivery of the herpes simplex virus thymidine kinase gene in glioma: improvement of cell sensitization to ganciclovir. Cancer Gene Ther 1996; 3 (6): 385–392.

    CAS  PubMed  Google Scholar 

  26. Kashima Y, Miki T, Minami K, Seino S . Establishment of a tet-on gene expression system in glucose-responsive and -unresponsive MIN6 cells. Diabetes 2001; 50 (Suppl): S133.

    Article  CAS  PubMed  Google Scholar 

  27. Mizuguchi H, Xu ZL, Sakurai F, Mayumi T, Hayakawa T . Tight positive regulation of transgene expression by a single adenovirus vector containing the rtTA and tTS expression cassettes in separate genome regions. Hum Gene Ther 2003; 14 (13): 1265–1277.

    Article  CAS  PubMed  Google Scholar 

  28. Kugawa F, Matsumoto K, Aoki M . Apoptosis-like cell death of human breast cancer cell line MCF-7 induced by buprenorphine hydrochloride. Life Sci 2004; 75 (3): 287–299.

    Article  CAS  PubMed  Google Scholar 

  29. Simoes-Wust AP, Schurpf T, Hall J, Stahel RA, Zangemeister-Wittke U . Bcl-2/bcl-xL bispecific antisense treatment sensitizes breast carcinoma cells to doxorubicin, paclitaxel and cyclophosphamide. Breast Cancer Res Treat 2002; 76 (2): 157–166.

    Article  PubMed  Google Scholar 

  30. Harwell RM, Mull BB, Porter DC, Keyomarsi K . Activation of cyclin-dependent kinase 2 by full length and low molecular weight forms of cyclin E in breast cancer cells. J Biol Chem 2004; 279 (13): 12695–12705.

    Article  CAS  PubMed  Google Scholar 

  31. Keyomarsi K, Tucker SL, Buchholz TA, Callister M, Ding Y, Hortobagyi GN et al. Cyclin E and survival in patients with breast cancer. N Engl J Med 2002; 347 (20): 1566–1575.

    Article  CAS  PubMed  Google Scholar 

  32. Paulovich AG, Toczyski DP, Hartwell LH . When checkpoints fail. Cell 1997; 88 (3): 315–321.

    Article  CAS  PubMed  Google Scholar 

  33. Agami R, Bernards R . Convergence of mitogenic and DNA damage signaling in the G1 phase of the cell cycle. Cancer Lett 2002; 177 (2): 111–118.

    Article  CAS  PubMed  Google Scholar 

  34. Nagle DG, Zhou YD, Mora FD, Mohammed KA, Kim YP . Mechanism targeted discovery of antitumor marine natural products. Curr Med Chem 2004; 11 (13): 1725–1756.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Tu LC, Melendy T, Beerman TA . DNA damage responses triggered by a highly cytotoxic monofunctional DNA alkylator, hedamycin, a pluramycin antitumor antibiotic. Mol Cancer Ther 2004; 3 (5): 577–585.

    CAS  PubMed  Google Scholar 

  36. Corban-Wilhelm H, Ehemann V, Becker G, Greulich D, Braun K, Debus J . Comparison of different methods to assess the cytotoxic effects of cytosine deaminase and thymidine kinase gene therapy. Cancer Gene Ther 2004; 11: 208–214.

    Article  CAS  PubMed  Google Scholar 

  37. Wang Y, Hu JK, Krol A, Li YP, Li CY, Yuan F . Systemic dissemination of viral vectors during intratumoral injection. Mol Cancer Ther 2003; 2 (11): 1233–1242.

    CAS  PubMed  Google Scholar 

  38. Patil R, Chavez JB, Yee D . Inducible expression of herpes simplex virus thymidine kinase increases sensitivity to ganciclovir but does not enhance bystander effect in breast cancer cells. Breast Cancer Res Treat 2000; 62 (2): 109–115.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by the grant from CMB (China Medical Board of New York Inc., Grant # 99-698).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to W-X Hu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zeng, ZJ., Li, ZB., Luo, SQ. et al. Retrovirus-mediated tk gene therapy of implanted human breast cancer in nude mice under the regulation of Tet-On. Cancer Gene Ther 13, 290–297 (2006). https://doi.org/10.1038/sj.cgt.7700889

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.cgt.7700889

Keywords

This article is cited by

Search

Quick links